Matches in Nanopublications for { ?s ?p "DDI between Tamoxifen and Lumefantrine - Lumefantrine, a moderate CYP2D6 inhibitor, may decrease the formation of highly potent tamoxifen metabolites. Concomitant therapy may decrease the effectiveness of tamoxifen. Consider alternate therapy."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.